ArticleDermatology and therapy2026

Real-World Evidence on Dose Spacing of Risankizumab for Psoriasis: A Multicenter Retrospective Cohort Study.

Martim Luz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.